# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-022735
Filing Date
2022-08-12
Accepted
2022-08-12 17:12:48
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20220630.htm iXBRL | 10-Q | 1085067
2 | EX-10.1 | pinnaclebank-cpiamend8tolo.htm | EX-10.1 | 147265
3 | EX-31.1 | a2022q2-exhibit311.htm | EX-31.1 | 12645
4 | EX-31.2 | a2022q2-exhibit312.htm | EX-31.2 | 12639
5 | EX-32.1 | a2022q2-exhibit321.htm | EX-32.1 | 6975
11 |  | imagea.jpg | GRAPHIC | 34109
| Complete submission text file | 0001628280-22-022735.txt |  | 4960565

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20220630.xsd | EX-101.SCH | 32870
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20220630_cal.xml | EX-101.CAL | 54079
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20220630_def.xml | EX-101.DEF | 137090
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20220630_lab.xml | EX-101.LAB | 407046
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20220630_pre.xml | EX-101.PRE | 269768
53 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20220630_htm.xml | XML | 673802

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 221161188
SIC: 2834 Pharmaceutical Preparations